据新华社电,美国一家生物制药公司12日说,它研制的一种针对产后抑郁症的药物在二期临床试验中显示出积极效果,所治疗的10名患者中有7人产后抑郁症状大幅缓解。据美国心理学会估计,高达七分之一的妇女在分娩后经历产后抑郁症,其症状因人而异,严重者可发生错觉或幻觉,甚至会有伤害自己或婴儿的想法。但目前还没有产后抑郁症专治药物获准上市。 According to Xinhua News Agency, a biopharmaceutical company in the United States said on the 12th that it has developed a positive drug for postpartum depression in Phase II clinical trials. Seven of 10 patients treated were significantly depressed in postpartum depression ease. According to the American Psychological Association, up to one in seven women experience postpartum depression after childbirth, and their symptoms vary from person to person. In severe cases, they may experience delusions or hallucinations and may even have the idea of ​​hurting themselves or their babies. However, no postpartum depression-specific drugs have been approved for listing.